Results 81 to 90 of about 989,686 (264)

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska   +13 more
wiley   +1 more source

Optimisation and validation of virtual physiological human lung models in asthma

open access: yes
Physiological tests assessing abnormal lung function due to ventilation (V) and perfusion (Q) mismatch, and ventilation heterogeneity (VH)–such as the CO gas transfer and forced oscillation techniques (FOT)–provide valuable but global measurements of ...
Nikolaou, Christos
core   +1 more source

MRI of the lung (3/3)-current applications and future perspectives [PDF]

open access: yes, 2011
BackgroundMRI of the lung is recommended in a number of clinical indications. Having a non-radiation alternative is particularly attractive in children and young subjects, or pregnant women.MethodsProvided there is sufficient expertise, magnetic ...
M. Both   +30 more
core   +2 more sources

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

Kalihi Lung Fung [PDF]

open access: yes
Chines
Kalihi Lung Fung
core  

Loss of IGF‐1R impairs DNA‐PKcs recruitment to chromatin leading to defective end‐joining

open access: yesMolecular Oncology, EarlyView.
IGF‐1R promotes radioresistance by facilitating DNA‐PKcs recruitment to chromatin, enabling non‐homologous end‐joining (NHEJ) repair of double‐strand breaks. Inhibition or loss of IGF‐1R disrupts this recruitment to damage sites, driving compensatory reliance on microhomology‐mediated end‐joining (MMEJ) repair.
Matthew O. Ellis   +3 more
wiley   +1 more source

Newfoundland Lung Association Newsletter; Lung Association of Newfoundland and Labrador Newsletter

open access: yes, 1982
The Northern Light, Summer 1982Contents Page -- The Cross of Lorraine or Double-Barred Cross -- Obituaries -- Editorial: 1982, A Year to Remember / E. G. House -- His Hon. W. Anthony Paddon, C.M. M.D.
Newfoundland Lung Association
core  

Flow Enabled Target Capture Halbach‐based magnetic enrichment increases circulating tumor cell capture from blood in metastatic cancer patients

open access: yesMolecular Oncology, EarlyView.
Pair‐wise comparison of the CellSearch and FETCH enrichment technologies for circulating tumor cells (CTCs) from metastatic breast, prostate, and small cell lung cancer patients shows an increased capture of CTCs using FETCH enrichment. The clinical implementation of circulating tumor cells (CTCs) as a predictive tool for therapy efficacy in the ...
Michiel Stevens   +6 more
wiley   +1 more source

Newfoundland Lung Association Newsletter; Lung Association of Newfoundland and Labrador Newsletter

open access: yes, 1986
The Northern Light, Campaign 1986Message from the President -- 1986 Christmas Seal Design -- Christmas Seals Being Prepared -- Newfoundlanders Complete Terms at National Level -- Meet Clyde! -- West Coast Advisory Board Planning Full Year -- Dr.
Newfoundland Lung Association
core  

Interstitial lung disease in Malta [PDF]

open access: yes, 2012
Aim: To establish the prevalence, management and response to treatment of interstitial lung disease (ILD) in Malta. Methodology: The personal files of 102 living and 26 deceased patients with ILD under the care of 4 respiratory physicians were reviewed ...
Fenech, Manwel   +2 more
core  

Home - About - Disclaimer - Privacy